B‐cell translocation gene 2 (BTG2) is a tumour suppressor protein known to be
downregulated in several types of cancer. In this study, we investigated a potential role for …

Background BTG3 (B-cell translocation gene 3) has been identified as a tumor suppressor
and hypermethylation contributes to its down-regulation in some tumors, but its role in …

Background B-cell translocation gene 2 (BTG2) has been revealed to be involved in the
occurrence and development of multiple cancers. However, the role of BTG2 in lung …

Background: B-cell translocation gene 1 (BTG1) acts as a tumour suppressor in human
malignancies. However, the precise mechanism of BTG1 down-regulation in colorectal …

Background/Aim: The mechanism responsible for B-cell translocation gene 1 (BTG1) down-
regulation in breast carcinoma remains unknown. We examined the BTG1 expression status …

Although the B‑cell translocation gene 1 (BTG1) plays an important role in apoptosis and
negatively regulates cell proliferation, BTG1 expression in hepatocellular carcinoma (HCC) …

Background This study aims to develop a prognostic model for overall survival based on
potential methylation sites within B-cell translocation gene 2 (BTG2) in Chinese patients with …

A better understanding of tumor biology is important in the identification of molecules that
are downregulated in malignancy and in determining their role in tumor suppression. B-cell …

Non–small lung cancer (NSCLC) is a common malignant disease with very poor outcome.
Accurate prediction of prognosis can better guide patient risk stratification and treatment …

Purpose B-cell translocation gene 3 (BTG3) has been identified as a candidate driver gene
for various cancers, but its specific role in colorectal cancer (CRC) is poorly understood. We …